# Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass

> **NCT06917859** · PHASE1 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 170 (estimated)

## Conditions studied

- Cardiopulmonary Bypass
- AKI - Acute Kidney Injury

## Interventions

- **DRUG:** Methylprednisolone group

## Key facts

- **NCT ID:** NCT06917859
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917859, "Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06917859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
